The involvement of RIPK4 in TNF- α-stimulated IL-6 and IL-8 production by melanoma cells
ConclusionThese data reveal a complex role for RIPK4 in regulating the immune signaling network in melanoma cells and suggest that this kinase may represent an alternative target for melanoma-targeted adjuvant therapy.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Genetics | Melanoma | Skin Cancer | Study